Crossject SA (ALCJ)
Euronext
Closed
Oct 9, 2026
Day's Range
1.2852 wk Range
1.19Overview - ALCJ - Crossject SA
Key Statistics
Valuation
Enterprise Value
76.14M
P/E (Forward)
‪2.53‬
PEG Ratio
‪2.53‬
Price / Sales (TTM)
‪580.70‬
EV / EBITDA
‪-5.33‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-10,853.28%‬
Return on Assets
‪-27.75%‬
Return on Equity
‪-1,498.24%‬
Ownership
Shares Outstanding
52.18M
Float
51.16M
Held by Insiders
‪19.74%‬
Held by Institutions
‪0.40%‬
Price stats
Beta
‪0.51‬
50-Day Avg
‪1.41‬
200-Day Avg
‪1.83‬
Analyst Consensus
2 analysts
Average price target
‪€ 4.40‬Market Cap - ALCJ - Crossject SA
Peers - ALCJ - Crossject SA
Peer Comparison
Compared with companies in Medical Instruments & Supplies listed on Euronext.
- ALCJEuronextCrossject SA79.55MMarket Cap-90.15%52-week change—P/E (Trailing)‪0.00%‬Profit Margin
- ELEuronextEssilorLuxottica65.50BMarket Cap-93.35%52-week change26.64P/E (Trailing)‪8.51%‬Profit Margin
- DIMEuronextSartorius Stedim Biotech S.A.20.66BMarket Cap+19.47%52-week change70.33P/E (Trailing)‪9.73%‬Profit Margin
- COVEuronextCovivio4.78BMarket Cap-28.99%52-week change7.35P/E (Trailing)‪55.91%‬Profit Margin
- SOLVEuronextSolvac S.A.1.92BMarket Cap+2.22%52-week change15.36P/E (Trailing)‪3,302,181.60%‬Profit Margin
- NYXHEuronextNyxoah SA131.37MMarket Cap-335.66%52-week change-0.55P/E (Trailing)‪63.13%‬Profit Margin
- ALVMGEuronextVisiomed Group SA40.59MMarket Cap-94.64%52-week change46.67P/E (Trailing)‪45.95%‬Profit Margin
Profile Summary - ALCJ - Crossject SA
About
Crossject SA is a France-based specialty pharmaceutical company that develops needle-free drug delivery systems for emergency medical use. Its core platform, ZENEO, is a prefilled, single-use auto-injector designed to help patients and untrained caregivers administer medication quickly and simply. The company focuses…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
